DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Effectiveness of Permethrin Impregnated Underwear in Preventing Louse Proliferation in Infected Homeless

Information source: Assistance Publique Hopitaux De Marseille
Information obtained from ClinicalTrials.gov on February 07, 2013
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Lice

Intervention: Permethrin impregnated (Drug); no Permethrin impregnated (Drug)

Phase: N/A

Status: Recruiting

Sponsored by: Assistance Publique Hopitaux De Marseille

Official(s) and/or principal investigator(s):
BERNARD BELAIGUES, Study Director, Affiliation: Assistance Publique hôpitaux de Marseille

Overall contact:
philippe BROUQUI, Email: philippe.brouqui@ap-hm.fr

Summary

Homelessness, also name the fourth world, is a growing public health problem worldwide. Previous studies showed that up to 30% of the homeless people reported pruritus that often results in itchy lesions, which expose them to bacterial skin infections.

The investigators therefore conducted a randomized, double-blind, placebo-controlled trial to test the hypothesis that a single oral dose of ivermectin was effective in significantly reducing the prevalence of pruritus in a sheltered homeless population.

Clinical Details

Official title: Effectiveness of Permethrin Impregnated Underwear in Preventing Louse Proliferation in Infected Homeless

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Primary outcome: Show that underwear soaked with permethrine in 8 % allow to reduce in a long-lasting way (J90 and J365) of 50 % the index of infestation and prevalency of the louses in the group treated with regard to the group placebo.

Secondary outcome: Show that underwear soaked with permethrine in 8 % allow to reduce in a long-lasting way (J90 and J365) of 50 % the index of infestation and prevalency of the louses in the group treated with regard to the group placebo.

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Patient HOMELESS PERSON " individual who has no regular access to a conventional

residence ", appearing during the period of study at reception centers (Forbin or Madrague Ville) and being in the habit of wearing there (at least 4 times a week),

- Male genital organ and feminine,

- Of more than 18 years old,

- Presenting of the prurit, hurts of scratching or the louses

- Wishing to change his underwear,

- Having given his lit(enlightened) consent

Exclusion Criteria:

- Woman presenting a sexually transmitted infection (infection with gonococcus, with

Chlamydia trachomatis, with Trichomonas vaginalis) revealing on the takings realized during the consultation of inclusion but the bacteriological results of which will be known only secondarily.

- Pregnant Woman presenting to the consultation of inclusion of métrorragies either a

break of the pocket of waters or an infectious complication of the pregnancy.

- Woman removing her consent during the study.

- Lost sight Woman.

- Woman deprived of freedom, judicial or administrative;

- Woman hospitalized for quite other reason that looks for her(it);

- Woman hospitalized in a sanitary establishment or social in the other purposes that

the research;

- Major Woman except state to express its consent

Locations and Contacts

philippe BROUQUI, Email: philippe.brouqui@ap-hm.fr

Assistance Publique Hopitaux de Marseille, Marseille 13354, France; Recruiting
philippe BROUQUI
Additional Information

Starting date: January 2011
Last updated: February 9, 2011

Page last updated: February 07, 2013

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014